NCT07713498Enrolling by invitation
Tapering of Inhaled Corticosteroids in Tezepelumab-treated Asthma patieNts: Impact on Clinical Outcomes
TITANIC - Tapering of Inhaled Corticosteroids in Tezepelumab-treated Asthma patieNts: Impact on Clinical Outcomes
Source: ClinicalTrials.gov · Last updated 21 Jul 2026
Brief summary (registry, in English)
To evaluate the relationship between starting tezepelumab treatment followed by tapering of inhaled corticosteroid (ICS) and ICS dose, metabolic outcomes, asthma control and exacerbation rate in a real world setting
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 61 (estimated)
- First submitted
- 1 May 2026
- Start date
- 1 May 2026
- Primary completion date
- Oct 2027
- Lead sponsor
- Franciscus Gasthuis
- Diseases
- Asthma
- NCT number
- NCT07713498
What you commit to
- Study type: Observational
- Planned participants: 61
- From 1 May 2026 to the primary completion date, Oct 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Other underlying inflammatory or auto-immune diseases that require OCS treatment, such as rheumatologic disease, IBD etc.
Other
- Pregnancy, because of the possible altered immunological status.
- Participation in an interventional study that interferes with this study.
Who the study is looking for
- Age ≥18
- Patient diagnosed with severe asthma according to the GINA guidelines
- Written informed consent (AVG).
- Eligibility and willingness to present during an asthma exacerbation at the Franciscus hospital.
- Patient has received/or has been planned for at least one dose of tezepelumab
- Sufficient understanding of the Dutch or English language
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Franciscus Gasthuis & Vlietland Coordinator of this site? Confirm its status | Rotterdam | Netherlands | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.